The dexamethasone suppression test in panic disorder and agoraphobia

Area of Science:

• Psychiatry
• Neuroendocrinology
• Clinical Psychology

Background:

• Imipramine and phenelzine are reported to alleviate panic attacks in agoraphobia.
• This observation raises the hypothesis that agoraphobia and/or panic disorder may represent manifestations of underlying depression.

Purpose of the Study:

• To investigate the potential link between panic disorder/agoraphobia and depression.
• To determine if patients with panic attacks exhibit the same dexamethasone suppression test (DST) abnormalities seen in endogenous depression.

Main Methods:

• Dexamethasone suppression tests (DSTs) were conducted on 10 patients with agoraphobia and panic attacks.
• DSTs were also performed on 6 patients with panic disorder and 4 patients with overlapping diagnoses.
• Abnormal DST results were analyzed for correlation with panic attacks and agoraphobia.

Main Results:

• Only 3 out of the 20 patients exhibited abnormal DST results.
• The observed abnormalities were not directly attributable to panic attacks or agoraphobia.
• The findings indicate a lack of significant DST abnormalities in patients with panic disorder or agoraphobia.

Conclusions:

• Panic attacks and endogenous depression appear to be distinct clinical disorders.
• The antipanic effects of imipramine and phenelzine are likely independent of their antidepressant properties.
• The study suggests that treatments for panic symptoms may not rely on mechanisms related to endogenous depression.